donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

GBT Global Blood Therapeutics

66.565
-0.035-0.05%
Trading Session 08/09 13:42 ET
High
66.660
Open
66.530
Turnover
343.77M
Low
66.460
Pre Close
66.600
Volume
5.16M
Market Cap
4.49B
P/E(TTM)
Loss
52wk High
73.020
Shares
67.46M
P/E(Static)
Loss
52wk Low
21.650
Float Cap
3.50B
Bid/Ask %
47.17%
Historical High
87.540
Shs Float
52.61M
Volume Ratio
0.62
Historical Low
12.240
Dividend TTM
--
Div Yield TTM
250
P/B
37.95
Dividend LFY
--
Div Yield LFY
375.57%
Turnover Ratio
9.81%
Amplitude
0.30%
Avg Price
66.589
Lot Size
1
Float Cap
3.50B
Bid/Ask %
47.17%
Historical High
87.540
Shs Float
52.61M
Volume Ratio
0.62
Historical Low
12.240
Dividend TTM
--
P/B
37.95
Dividend LFY
--
Turnover Ratio
9.81%
Amplitude
0.30%
Avg Price
66.589
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.
CEO: Love M.D., Ted W.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...